Hologic to acquire molecular diagnostics firm Biotheranostics for $230m
The acquisition of Biotheranostics will allow Hologic to leverage commercial capabilities and expertise in molecular diagnostics automation
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Jan 21
The acquisition of Biotheranostics will allow Hologic to leverage commercial capabilities and expertise in molecular diagnostics automation
30 Dec 20
If the discussions are fruitful, Moderna is expected to supply 40 million doses of mRNA-1273 vaccine in South…
21 Dec 20
The acquisition will combine Philips’ in-hospital patient monitoring capabilities with BioTelemetry’s monitoring capabilities outside the hospital
16 Dec 20
FDA authorised Ellume Covid-19 Home Test for non-prescription home use in symptomatic and asymptomatic individuals
11 Dec 20
Ensono developed the secure cloud-based infrastructure for PIONEER hub, in collaboration with Microsoft, HDR UK, the University of…
02 Dec 20
The acquisition will increase AdaptHealth’s footprint to 47 continental US states
16 Nov 20
Janssen will commit around $604m and BARDA nearly $454m to support the ongoing Phase 3 ENSEMBLE trial programme
11 Nov 20
SUTAB tablets with active sulphate ingredients provide gastroenterologists with new, safe, and effective alternative to liquid bowel preparations
04 Nov 20
bioLytical developed INSTI HIV Self Test to provide more than 99% accurate results within one minute, using one…
03 Nov 20
The EnSite X EP System is an advanced cardiac mapping system designed to optimise cardiac ablation procedures in…